Clinical Trial Update: Exemestane in Post-Menopausal Women With NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating exemestane in post-menopausal women with non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Exemestane (Exemestane)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-05-31